Details

Product number
6228301
CPT
-
Packaging group
4 x 986
Unit
ml
Composition
I) Glucoselösung 42 %: glucosum 125 g ut glucosum monohydricum, acidum hydrochloridum, aqua ad iniectabile ad solutionem pro 298 ml. II) Aminosäurenlösung: alaninum 7 g, argininum 6 g, glycinum 5.5 g, histidinum 1.5 g, isoleucinum 2.5 g, leucinum 3.7 g, lysinum anhydricum 3.3 g ut lysini acetas, methioninum 2.2 g, phenylalaninum 2.6 g, prolinum 5.6 g, serinum 3.2 g, taurinum 0.5 g, threoninum 2.2 g, tryptophanum 1 g, tyrosinum 0.2 g, valinum 3.1 g, acidum aceticum glaciale, aqua ad iniectabile ad solutionem pro 500 ml. III) Fettemulsion: sojae oleum raffinatum 11.3 g, triglycerida media 11.3 g, olivae oleum raffinatum 9.4 g, piscis oleum 5.6 g, int-rac-alpha-tocopherolum, phospholipida ex ovo purificata, glycerolum, natrii oleas, natrii hydroxidum, aqua ad iniectabile ad emulsionem pro 188 ml. I) et II) et III) corresp.: aminoacida 50 g, nitrogenia 8 g, carbohydrata 125 g, materia crassa 37 g, in emulsione recenter mixta 986 ml. Corresp. 4600 kJ pro 986 ml corresp. natrium 6.39 mg.

Articles (1)

SmofKabiven EF, Infusionsemulsion 986 ml
Infusionsemulsion
4 x 986
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
24/08/2026
Professional SmPC
Français
24/08/2026
Professional SmPC
Italien
24/08/2026

Detailed composition

Substance Quantity Type Category
sojae oleum raffinatum
11.3 G Substance Wirkstoff (Principe actif)
glucosum
125.0 G Substance Wirkstoff (Principe actif)
alaninum
7.0 G Substance Wirkstoff (Principe actif)
aminoacida
50.0 G Substance Wirkstoff (Principe actif)
argininum
6.0 G Substance Wirkstoff (Principe actif)
nitrogenia
8.0 G Substance Wirkstoff (Principe actif)
triglycerida media
11.3 G Substance Wirkstoff (Principe actif)
glucosum monohydricum
- Substance WIZUS
carbohydrata
125.0 G Substance Wirkstoff (Principe actif)
acidum hydrochloridum
- Substance HNIDK
olivae oleum raffinatum
9.4 G Substance Wirkstoff (Principe actif)
glycinum
5.5 G Substance Wirkstoff (Principe actif)
piscis oleum
5.6 G Substance Wirkstoff (Principe actif)
materia crassa
37.0 G Substance Wirkstoff (Principe actif)
histidinum
1.5 G Substance Wirkstoff (Principe actif)
aqua ad iniectabile
- Substance HNIDK
isoleucinum
2.5 G Substance Wirkstoff (Principe actif)
int-rac-alpha-tocopherolum
- Substance HNIDK
phospholipida ex ovo purificata
- Substance HNIDK
leucinum
3.7 G Substance Wirkstoff (Principe actif)
lysinum anhydricum
3.3 G Substance Wirkstoff (Principe actif)
glycerolum
- Substance HNIDK
natrii oleas
- Substance HNIDK
lysini acetas
- Substance WIZUS
natrium
6.39 MG Substance HBESI
natrii hydroxidum
- Substance HNIDK
methioninum
2.2 G Substance Wirkstoff (Principe actif)
aqua ad iniectabile
- Substance HNIDK
phenylalaninum
2.6 G Substance Wirkstoff (Principe actif)
prolinum
5.6 G Substance Wirkstoff (Principe actif)
serinum
3.2 G Substance Wirkstoff (Principe actif)
taurinum
0.5 G Substance Wirkstoff (Principe actif)
threoninum
2.2 G Substance Wirkstoff (Principe actif)
tryptophanum
1.0 G Substance Wirkstoff (Principe actif)
tyrosinum
0.2 G Substance Wirkstoff (Principe actif)
valinum
3.1 G Substance Wirkstoff (Principe actif)
acidum aceticum glaciale
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Fresenius Kabi (Schweiz) AG

6010 Kriens

Authorization information

Swissmedic authorization number
62283
Drug name
SmofKabiven EF, Infusionsemulsion
Galenic form
EMUI
ATC Code
B05BA10
Authorization status
Z
Dispensation category
B
First authorization
10/08/2012
Authorization expiration date
31/12/9999
IT number
07.01.2.
Domain
Human medicine
Field of application
Parenterale Ernährung für Erwachsene

Packaging details

Description (FR)
SMOFKABIVEN EF émuls perf 986ml 4 pce
Description (DE)
SMOFKABIVEN EF Inf Emuls 986ml 4 Stk
Market launch
10/08/2012
Narcotic (BTM)
No

Other packaging sizes

SMOFKABIVEN EF émuls perf 1477ml 4 pce
4 x 1477 ML
View
Buy us a coffee Explore the data